Statins: is there a need for alternative or adjunctive therapy?
作者信息
Shepherd J
机构信息
Department of Pathological Biochemistry, Royal Infirmary, Glasgow.
出版信息
Br Heart J. 1995 Jul;74(1):13. doi: 10.1136/hrt.74.1.13.
Abstract
摘要
相似文献
1
Statins: is there a need for alternative or adjunctive therapy?他汀类药物：是否需要替代疗法或辅助疗法？
Br Heart J. 1995 Jul;74(1):13. doi: 10.1136/hrt.74.1.13.
2
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.降脂治疗与冠心病事件：空军/德克萨斯冠状动脉粥样硬化预防研究（AFCAPS/TexCAPS试验）
JAMA. 1999 Feb 3;281(5):415; author reply 417-9.
3
Statins for stroke: the second story?他汀类药物与中风：新的情况？
Circulation. 2001 Jan 23;103(3):348-50. doi: 10.1161/01.cir.103.3.348.
4
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.斯堪的纳维亚辛伐他汀生存研究（4S）糖尿病受试者亚组分析：对冠心病预防的启示
Diabetes Care. 1997 Apr;20(4):469-71. doi: 10.2337/diacare.20.4.469.
5
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.HMG-CoA还原酶抑制剂的药效学与药代动力学。异同点。
Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.
6
7
[The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].[4S研究——胆固醇争论的转折点。瑞士心脏病学会脂质与动脉粥样硬化工作组]
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1514-6.
8
Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease.
Arch Intern Med. 1997 Jun 23;157(12):1283-4.
9
Statins do more than just lower cholesterol.他汀类药物的作用不止于降低胆固醇。
Lancet. 1996 Oct 19;348(9034):1079-82. doi: 10.1016/S0140-6736(96)05190-2.
10
Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.与辛伐他汀-吉非贝齐联合治疗相关的横纹肌溶解症。
South Med J. 1997 May;90(5):546-7. doi: 10.1097/00007611-199705000-00018.
本文引用的文献
1
HMG CoA reductase inhibitors.HMG辅酶A还原酶抑制剂
Curr Opin Lipidol. 1994 Feb;5(1):59-68. doi: 10.1097/00041433-199402000-00010.
2
Mechanism of action of fibrates.
Postgrad Med J. 1993;69 Suppl 1:S34-41.
3
Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety.贝特类药物和他汀类药物治疗高脂血症：对其疗效和安全性的评估
Eur Heart J. 1995 Jan;16(1):5-13. doi: 10.1093/eurheartj/16.1.5.
4
Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.他汀类药物与贝特类药物联合治疗冠心病患者高胆固醇血症的长期安全性
Br Heart J. 1995 Jul;74(1):14-7. doi: 10.1136/hrt.74.1.14.
5
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.用于治疗高胆固醇血症的HMG-CoA还原酶抑制剂。
N Engl J Med. 1988 Jul 7;319(1):24-33. doi: 10.1056/NEJM198807073190105.
Zotero 插件